The Therapeutic Potential of Ayahuasca


Herbal medicine

Dosage

Major/Active Constituents

Key evidence

Potential AEs

Potential clinical use

Clinical advice

Ayahuasca ( Psychotria viridis plus Banisteriopsis caapi; or B. caapi plus Diplopterys cabrerana)

Variable dosage

MAOI:

Harmine, harmaline, and tetrahydroharmine

Dimethyltryptamine (DMT)

Upregulation of serotonin transporters; Research indicates anxiolytic effects and therapeutic potential to treat depression as well as substance dependence

Adverse reactions associated with “serotonin syndrome” have been reported when used in conjunction with SSRIs

Panic Disorder, Hoplessness,

Treatment for substance dependence (cocaine, crack cocaine, alcohol, tobacco)

Important to consider set and setting.

May have adverse effects if use is in close proximity to that of SSRIs, alcohol, hypnotics and sedatives. Future clinical research is warranted



In light of the widespread use of ayahuasca in a context of a changing world, there are important clinical considerations in terms of the potential adverse effects of ayahuasca use in combination with antidepressants, hypnotics and sedatives, and/or alcohol. It has been cautioned that the use of ayahuasca in conjunction with SSRI type antidepressants may result in “serotonin syndrome”due to the mechanistic action of both DMT as a 5-HT agonists and the inhibition of metabolic breakdown of serotonin transporters by MAOI [15, 39]. Further, it has been noted that the potential adverse effects from active metabolites may persist up to 5 weeks after discontinued use of SSRIs [39]; therefore, individuals employing the use of ayahuasca as a complementary approach to conventional psychotherapy and/or personal development should take the necessary precautions. In addition, in order to maximize harm reduction it is important for ayahuasca users to consider other potentially adverse interactions with the combination of ayahuasca and other drugs such as alcohol and certain foods. This said, there is perhaps wisdom in traditional dietary proscriptions employed by cultural practitioners (i.e., vegetalistas) who have long been aware of the potential adverse effects of the combination of ayahuasca and these substances – an area also in need of further investigation.



References



1.

Grob CS et al. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J Nerv Ment Dis. 1996;184(2):86–94.CrossRefPubMed


2.

McKenna DJ, Luna LE, Towers GH. Biodynamic constituents in ayahuasca admixture plants. In: von Reis S, Schultes RE, editors. Ethnobotany: evolution of a discipline. Portland: Dioscorides Press; 1995.


3.

Luna LE. Indigenous and mestizo use of ayahuasca: an overview. In: Santos RE d, editor. The ethnopharmacology of ayahuasca. Trivandrum: Transworld Research Network, Kerala; 2011. p. 1–21.


4.

Santos RG et al. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. J Ethnopharmacol. 2007;112(3):507–13.CrossRefPubMed


5.

McKenna DJ. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenge. PharmacolTher. 2004;102(2):111–29.


6.

Callaway JC et al. Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol. 1999;65(3):243–56.CrossRefPubMed

Apr 12, 2018 | Posted by in PSYCHIATRY | Comments Off on The Therapeutic Potential of Ayahuasca

Full access? Get Clinical Tree

Get Clinical Tree app for offline access